45 search results for: disease control

Type 2 Inflammation: Links With Severe Un<b>control</b>led CRSwNP
Rhinology
Type 2 Inflammation: Links With Severe Uncontrolled CRSwNP
expert video

In this video soundbite from the ERS-ISIAN 2025 symposium, Dr. Vibeke Backer discusses how Type 2 inflammation drives severe, uncontrolled CRSwNP. It covers key immune cells and biomarkers (e.g., IL-4, IL-5, IL-13, TSLP), global prevalence differences, and the importance of symptom tracking and targeted therapies.

View more
ERS 2026 | Breaking Silos Between Asthma and CRSwNP: Loss of Smell as a Marker of Unified Airway <b>Disease</b>
Pulmonology
ERS 2026 | Breaking Silos Between Asthma and CRSwNP: Loss of Smell as a Marker of Unified Airway Disease
expert video

Join experts Roland Buhl, Joaquim Mullol, and Giselle Mosnaim as they discuss the role of type 2 inflammation across the unified airway, with a focus on the amplified burden and the difficulty controlling inflammation when asthma and CRSwNP coexist.

View more
Digging Deeper: Reducing Non-Atopic Comorbidities and Multidimensional <b>Disease</b> Burden
Dermatology
Digging Deeper: Reducing Non-Atopic Comorbidities and Multidimensional Disease Burden
expert video

In this video from the April 2025 WCPD symposium, Dr Paula Luna discusses the multidimensional disease burden in pediatric patients with AD and the data regarding how early intervention may lead to long-term disease control and a reduced risk of developing non-atopic comorbidities.

View more
Navigating Complex Definitions: Early Intervention and <b>Disease</b> Modification in Atopic Dermatitis
Dermatology
Navigating Complex Definitions: Early Intervention and Disease Modification in Atopic Dermatitis
expert video

Dr. Amy Paller discusses the evolving concepts of early intervention and disease modification in AD and describes potential biomarkers of subclinical control at EADV 2025.

View more
Digestive <b>Disease</b> Week 2024 | Washington D.C.
Awareness Day
18
May
2024
Awareness Day
Digestive Disease Week 2024 | Washington D.C.

Join ADVENT at the Digestive Disease Week 2024 Congress and visit the Sanofi and Regeneron Medical Booth # 1707.

CLCI in Atopic Dermatitis Infographic
Dermatology
CLCI in Atopic Dermatitis Infographic
Infographic

This infographic highlights how uncontrolled moderate‑to‑severe atopic dermatitis (AD) can lead to Cumulative Life Course Impairment (CLCI) by contributing to ongoing physical, psychological, and social burdens such as itch and sleep loss, impaired bone growth and mental health challenges. It emphasizes the importance of early and effective disease control to help reduce long‑term impact on patients.

View more
Beyond Signs and Symptoms: Broadening Treatment Goals in Dermatology
Dermatology
Beyond Signs and Symptoms: Broadening Treatment Goals in Dermatology
expert video

Dr Lawrence Eichenfield explores the broadening of treatment goals for long-term disease control, highlighting the importance of this approach in atopic dermatitis. Drs Culton, Elmariah, and Hawkes expand the discussion to further examine specific management goals unique to each skin disease (bullous pemphigoid, prurigo nodularis, and chronic spontaneous urticaria).

View more
ADVENT at EAACI 2025
Congress
13
June
2025
Congress
ADVENT at EAACI 2025

Join Profs. Brian Lipworth, Zuzana Diamant, and Philippe Gevaert at an sponsored symposium about the latest strategies for the management of co-existing type 2 asthma and severe and/or uncontrolled CRSwNP.

2025 ADVENT Forum | Joint Plenary Session: A View into the Life of Our Patients Video
Type 2 Inflammation
2025 ADVENT Forum | Joint Plenary Session: A View into the Life of Our Patients Video
expert video

This cross-TA plenary session addressed challenges in type 2 inflammation-driven diseases. Esteemed faculty, including Profs Klaus Rabe, Sharon Dell, Anju Peters, Milli Gupta, Eric Simpson, Stella Lee, and moderator Oscar Palomares, discussed strategies to enhance quality of life, reduce disease burden, and prioritize patient-centered care.

View more
Giselle Mosnaim
Expert
Giselle Mosnaim, MD, MS, FAAAAI, FACAAI

Giselle Mosnaim is a board-certified allergist and immunologist at Endeavor Health and Clinical Assistant Professor at the University of Chicago Pritzker School of Medicine. An internationally recognized expert in asthma and allergic diseases, her clinical and research interests focus on severe and uncontrolled asthma, digital health, and improving patient outcomes through innovative, evidence-based care.

Connecting Type 2 Inflammation to CRSwNP
Rhinology
Connecting Type 2 Inflammation to CRSwNP
expert video

Prof. Claus Bachert describes how type 2 inflammation drives CRSwNP.

View more
Essential Tools for Effective Care of Patients With Chronic Spontaneous Urticaria
Dermatology
Essential Tools for Effective Care of Patients With Chronic Spontaneous Urticaria
expert video

Tune in as Dr. Jason Hawkes describes how to assess disease activity in chronic spontaneous urticaria.

View more